HistoSonics Closed $250M Funding To Expand, But IPO ‘Not Immediate Priority,’ Says CEO

 
• By Marion Webb
  
HistoSonics' Edison histotripsy system is an image-guided, non-invasive therapy that uses focused acoustic energy to mechanically destroy targeted tissue without heat, ionizing radiation or incisions. (HistoSonics)

More from Financing

More from Business